Antiaging Quantum Living Inc.
AAQL
$0.988
$0.676216.67%
| Weiss Ratings | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Price History | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -6.79% | |||
| 90-Day Total Return | -1.20% | |||
| Year to Date Total Return | -6.79% | |||
| 1-Year Total Return | 12.55% | |||
| 2-Year Total Return | 339.11% | |||
| 3-Year Total Return | 182.29% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -6.79% | |||
| 52-Week Low % Change | 216.68% | |||
| Price | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.06 | |||
| 52-Week Low Price | $0.31 | |||
| 52-Week Low Price (Date) | Mar 28, 2025 | |||
| 52-Week High Price (Date) | Nov 27, 2024 | |||
| Valuation | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.64M | |||
| Enterprise Value | 31.85M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 307.69% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 56.14 | |||
| Price/Book (Q) | -31.37 | |||
| Enterprise Value/Revenue (TTM) | 60.11 | |||
| Price | $0.99 | |||
| Enterprise Value/EBITDA (TTM) | -42.04 | |||
| Enterprise Value/EBIT | -36.51 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 30.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 347 313 8992 | |||
| Address | 133-27 39th Avenue Flushing, NY 11354 | |||
| Website | www.aaql.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -164.64% | |||
| Profit Margin | -151.49% | |||
| Management Effectiveness | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -42.33% | |||
| Return on Equity | -- | |||
| Income Statement | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 529.80K | |||
| Total Revenue (TTM) | 529.80K | |||
| Revenue Per Share | $0.02 | |||
| Gross Profit (TTM) | 510.00K | |||
| EBITDA (TTM) | -757.50K | |||
| EBIT (TTM) | -872.30K | |||
| Net Income (TTM) | -802.60K | |||
| Net Income Avl. to Common (TTM) | -802.60K | |||
| Total Revenue Growth (Q YOY) | 2,352.38% | |||
| Earnings Growth (Q YOY) | -33.06% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -34.38% | |||
| Balance Sheet | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 202.50K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 659.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -945.60K | |||
| Current Ratio (Q) | 1.803 | |||
| Book Value Per Share (Q) | -$0.03 | |||
| Total Assets (Q) | 1.58M | |||
| Total Current Liabilities (Q) | 365.80K | |||
| Total Debt (Q) | 2.41M | |||
| Total Liabilities (Q) | 2.52M | |||
| Total Common Equity (Q) | -945.60K | |||
| Cash Flow | AAQL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -115.60K | |||
| Cash from Financing (TTM) | 896.90K | |||
| Net Change in Cash (TTM) | 74.10K | |||
| Levered Free Cash Flow (TTM) | -542.30K | |||
| Cash from Operations (TTM) | -702.50K | |||
